Table 4 |
||||||||
|
Reactivity profile of Sm-positive/dsDNA-positive sera |
||||||||
|
Sample ID |
ALBIAa |
ELISA |
ELISA dsDNA |
Crithidia luciliae dsDNA |
||||
|
|
||||||||
|
RNP |
Sm |
RNP/Sm |
SmD |
SmD1 |
SmD3 |
|||
|
|
||||||||
|
25480 |
435 |
396 |
9.2 |
4.8 |
189.1 |
11.2 |
3.9 |
Positive |
|
25719 |
217 |
212 |
2.1 |
0.9 |
188.9 |
4.4 |
5.1 |
Positive |
|
25794 |
487 |
1126 |
7.4 |
5.6 |
192.0 |
7.7 |
1.8 |
Positive |
|
26301 |
167 |
330 |
6.1 |
1.2 |
183.2 |
>100.0 |
2.1 |
Positive |
|
26488 |
126 |
127 |
1.0 |
0.6 |
17.2b |
0.5b |
1.8 |
Positive |
|
27224 |
265 |
607 |
7.8 |
4.5 |
190.1 |
88.2 |
2.9 |
Positive |
|
27960 |
165 |
326 |
7.8 |
5.7 |
182.5 |
23.2 |
3.3 |
Positive |
|
28077 |
250 |
527 |
9.0 |
5.6 |
182.0 |
73.7 |
4.8 |
Positive |
|
28242 |
65 |
102 |
4.0 |
1.6 |
71.2 |
0.7 |
11.1 |
Positive |
|
28746 |
143 |
169 |
4.3 |
2.6 |
181.3 |
1.1 |
9.2 |
Positive |
|
29236 |
98 |
164 |
5.9 |
1.7 |
182 |
264 |
6.8 |
Positive |
|
29354 |
450 |
225 |
4.0 |
2.1 |
32.4 |
4.2 |
12.1 |
Positive |
|
29659 |
161 |
132 |
4.9 |
2.2 |
30.1 |
3.3 |
11.6 |
Positive |
|
29861 |
496 |
205 |
8.9 |
4.5 |
19.2b |
3.3b |
1.6 |
Positive |
|
29907 |
538 |
520 |
9.3 |
6.2 |
185.0 |
243.0 |
12.2 |
Positive |
|
30015 |
376 |
632 |
9.6 |
7.1 |
184.3 |
>100.0 |
5.0 |
Positive |
|
31349 |
83 |
149 |
8.2 |
4.2 |
193.5 |
46.8 |
10.7 |
Positive |
|
34249 |
348 |
140 |
8.1 |
4.6 |
>200.0 |
13.4 |
5.1 |
Positive |
|
35784 |
494 |
553 |
8.9 |
5.6 |
>200.0 |
>100.0 |
8.3 |
Positive |
|
Number/number positive |
19/19 |
19/19 |
18/19 |
16/19 |
14/19 |
9/19 |
19/19 |
19/19 |
|
|
||||||||
|
aThe sample value in luminescence units(LU) can be classified as: negative, <20 LU; weak positive, 20–49 LU; moderate positive, 50–100 LU; strong positive, >100 LU.bdsDNA-positive/SmD-negative samples. ALBIA = Addressable laser bead assay. |
||||||||
|
Mahler et al. Arthritis Research & Therapy 2007 9:R68 doi:10.1186/ar2266 |
||||||||
